Instituto de Salud Carlos III
Work Package 1. Prevalence and related social and economic costs.WP leader: Manuel Posada, ISCIII
Aims: Estimation of the prevalence for ASD as a whole as well as by diagnostic subtype in the European Union and estimation of related social and economic burden;
Task 1.1. European Prevalence of ASD in 12 pilot areas.
Task 1.2. Burden of ASD Lead: Martin Knapp and Pedro Serrano, LSE & BioAvance
This task includes as different but related subtasks, the estimation of both the Health Burden (1.2.1) and the Economic Burden (1.2.2)
Task 1.2.1. Health burden of ASD
Objective: To estimate the Health burden of ASD in 12 European countries.
Task 1.2.2. Economic burden of ASD.
Objective 1: Estimating the economic impact of ASD on society in different EU countries
Task 1.3. Economic impact of a screening program for ASD
Objective 2: Estimating the economic impact of implementing a screening program for ASD in different EU countries.Instituto de Salud Carlos III